Combining a targeted drug, palbociclib with hormone therapy substantially extends survival for women with advanced breast cancer, according to a major new study published in the latest issue of the New England Journal of Medicine. Women taking palbociclib together with hormone therapy lived seven months longer than those on hormone treatment alone – adding to […]
Palbociclib targets advanced breast cancer
